Differential Metabolic Signature of Stroke Patients Undergoing Thrombolysis "DETECT"

Not yet recruiting

Phase N/A Results N/A

Summary of Purpose

Currently, there is no reliable biomarker for stroke, meaning that treatment is often delayed and patients are often left with a disability. Stroke is one of the largest causes of mortality (death) and morbidity (disease) in the UK and affects around 120 and 15 people per 100,000 population. This has huge economic implications, with around £9 billion a year being spent on stroke in the UK alone, and health and...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 16 February 2018.

1 Mar 2018 16 Feb 2018 1 Mar 2019 1 Mar 2019 1 Feb 2018 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

Not available

Contacts